Cascade Biotechnology INC | Complement Therapeutics; novel approach to CNS/PNS disease management using the innate complement system.


NIH Funding

Grant Number: 1 R43 HL139170-01A1 Principal Investigator: Fritzinger, David Charles Project Title: Preparation and development of a stabilized C3 analog for the treatment of paroxysmal nocturnal hemoglobinemia Institution: CASCADE BIOTECHNOLOGY Award Issue Date: 09/21/2018